Search
Search Results
##search.searchResults.foundPlural##
-
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3818PDF: 1683HTML: 11633Figures Haase: 207 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1423PDF: 492HTML: 3976 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1409PDF: 778HTML: 946 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2956PDF: 1601HTML: 239 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1334PDF: 877HTML: 1036Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 184 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1812PDF: 715HTML: 404 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12412PDF: 1685HTML: 4214Cover letter: 205Figure 1: 213 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2285PDF: 897HTML: 2006Fig 1 Rossi: 185 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2582PDF: 1172HTML: 145 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3404PDF: 1299HTML: 2230Fi.1 Gritti.Rambaldi: 210 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4823PDF: 2871HTML: 2311 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2204PDF: 988HTML: 3007Untitled: 214 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3229PDF: 789HTML: 2973Figure 1a and 1b: 154Figure 2: 164Figure 3: 182Figure 4: 166Figure 5: 168Tables 1-5: 156 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1581PDF: 1044HTML: 238 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1421PDF: 1327HTML: 101 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2891PDF: 1453HTML: 3058Cover Letter: 213 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1418PDF: 883HTML: 7981Untitled: 203 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2437PDF: 1601HTML: 651 -
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3283PDF: 1722HTML: 1099 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1564PDF: 918HTML: 1968Figure: 175Tables: 192ALL revision 1: 248response to reviewer: 186 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4032PDF: 1535HTML: 9192Untitled: 284Untitled: 192Untitled: 176Untitled: 170Untitled: 194Untitled: 348 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3263PDF: 1592HTML: 267 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1186PDF: 824HTML: 213 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
779PDF: 556HTML: 174 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
219PDF: 244Suppl. Files: 42HTML: 22 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3182PDF: 978HTML: 3137flowcytometric result of peripheral blood sample: 186 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1270PDF: 1017HTML: 226 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2225PDF: 1177HTML: 2595Study of serum haptoglobin level in thalassemia: 352Figures: 185 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277698PDF: 1811HTML: 3875 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4157PDF: 1017HTML: 19178







